TauRx Presents at the Royal Society of Medicine
TauRx Presents at the Royal Society of Medicine
Professor Claude Wischik, CEO and co-founder of TauRx, presented at the final session of a four-part webinar series on dementia for the Royal Society of Medicine 26 May 2021.
The session examined the role of the tau tangle in the pathophysiology of Alzheimer's disease and the anticipated impact of a novel therapeutic approach in late-stage development followed by an engaging panel session.
Quick off the mark, one participant wrote "I’ve just listened to the most fantastic talk hosted by the RSM by Professor Claude Wischik and he mentioned that this poster was available." A dedicated educational website on tau pathology, with several free downloadable resources, can be accessed here www.targetingtau.com or by clicking here
Recent News
TauRx celebrates winning the Research & Development Achievement category at the Pharma Industry Awards UK 2023.
Oct 25, 2023
GT Diagnostics announces release of self-administered assessment tool aiding diagnosis of dementia, HiPAL Pro.
Sep 05, 2023
#AAIC23 may have come to a close, but we left Amsterdam with key insights that will drive our work this year.
Jul 21, 2023
TauRx’s hydromethylthionine mesylate (HMTM) demonstrates significant reduction in neurodegeneration in Alzheimer’s Disease (AD)
Jul 16, 2023